These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 440766)

  • 21. [Serum hepatitis. An accumulation of cases after the use of contaminated "human serum"].
    Nielsen J; Vorting J; Knudsen EE
    Ugeskr Laeger; 1968 Jul; 130(27):1117-20. PubMed ID: 5701079
    [No Abstract]   [Full Text] [Related]  

  • 22. [Transfusion-hepatitis, the problem in the field of blood transfusion].
    Krebs HJ
    Schweiz Rundsch Med Prax; 1973 Sep; 62(36):1099-104. PubMed ID: 4728429
    [No Abstract]   [Full Text] [Related]  

  • 23. [Transfusion hepatitis].
    Haussmann HG
    Landarzt; 1967 Jul; 43(19):899-905. PubMed ID: 5616133
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hepatitis following blood transfusions].
    Busch H; Roos D; Creutzfeldt W
    Dtsch Med Wochenschr; 1971 Oct; 96(43):1694-6. PubMed ID: 5099201
    [No Abstract]   [Full Text] [Related]  

  • 25. [Transfusion hepatitis and inoculation hepatitis in the laboratory].
    Stampfli K
    Med Lab (Stuttg); 1969 Aug; 22(8):178-86. PubMed ID: 5351057
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hepatitis hazards through blood and blood products and possibilities of hepatitis prevention].
    Meyer KH; Bolte JP
    Internist (Berl); 1974 Sep; 15(9):471-8. PubMed ID: 4607645
    [No Abstract]   [Full Text] [Related]  

  • 27. Leg vein thrombosis diagnosed by 125I-fibrinogen test after acute myocardial infarction.
    Kotilainen M; Ristola P; Ikkala E; Pyörälä K
    Ann Clin Res; 1973 Dec; 5(6):365-8. PubMed ID: 4792200
    [No Abstract]   [Full Text] [Related]  

  • 28. Fibrinogen-transmitted hepatitis in the surgical patient.
    Boeve NR; Winterscheid LC; Merendino KA
    Ann Surg; 1969 Nov; 170(5):833-8. PubMed ID: 4186790
    [No Abstract]   [Full Text] [Related]  

  • 29. 125I fibrinogen and hepatitis.
    Croft D
    N Engl J Med; 1971 May; 284(20):1159. PubMed ID: 5553495
    [No Abstract]   [Full Text] [Related]  

  • 30. [The risk of hepatitis when using blood and blood products].
    Espmark A
    Lakartidningen; 1972 Dec; 69():Suppl 4:72-5. PubMed ID: 4656853
    [No Abstract]   [Full Text] [Related]  

  • 31. [Recommendations concerning anti-HBs in transfusion blood and application of anti-hepatitis B immunoglobulin concentrations in the prevention of hepatitis B].
    van Loghem JJ
    Ned Tijdschr Geneeskd; 1979 Oct; 123(43):1874-5. PubMed ID: 514376
    [No Abstract]   [Full Text] [Related]  

  • 32. [Additional possibilities of detection of the sources of viral hepatitis in blood recipients].
    Grinshteĭn EA; Aleĭnik MD; Makarevich IK
    Sov Med; 1978 May; (5):96-9. PubMed ID: 675327
    [No Abstract]   [Full Text] [Related]  

  • 33. [Enzyme prevention of post-transfusion hepatitis].
    Mazhinskaia VP
    Vestn Khir Im I I Grek; 1970 Dec; 105(12):58-60. PubMed ID: 5514434
    [No Abstract]   [Full Text] [Related]  

  • 34. [Characteristics of the epidemology and clinical picture of serum hepatitis].
    Kirilenko VA
    Vrach Delo; 1972 Feb; 2():140-4. PubMed ID: 5084729
    [No Abstract]   [Full Text] [Related]  

  • 35. 'How frequent is posttranfusion hepatitis after the introduction of 3rd generation donor screening for hepatitis B? What is its probable nature?
    Vox Sang; 1977; 32(6):346-63. PubMed ID: 898833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B antigen - post transfusion studies in Papua New Guinea.
    Woodfield DG
    Trop Geogr Med; 1977 Sep; 29(3):257-65. PubMed ID: 595131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Contribution to the evaluation of the fibrinogen test].
    Vodicková L; Malý J
    Vnitr Lek; 1983 Jul; 29(7):672-5. PubMed ID: 6613035
    [No Abstract]   [Full Text] [Related]  

  • 38. Hazards of blood and blood products. Case report of post-transfusion hepatitis-B.
    Wirtz CE; Kirchner JP; Maloney PM
    Wis Med J; 1985 May; 84(5):10-1. PubMed ID: 4013365
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serum (postransfusion) hepatitis developing against the background of long-term glucocorticosteroid therapy].
    Brodov LE; Ingerman BM
    Ter Arkh; 1971 Oct; 43(10):42-4. PubMed ID: 5140950
    [No Abstract]   [Full Text] [Related]  

  • 40. [Remarks on the problem of Australia antigen as an etiologic factor in the outbreak of viral hepatitis].
    Drews J; Sachs V; Waldvogel B
    Dtsch Med Wochenschr; 1971 Nov; 96(48):1893-4. PubMed ID: 5119935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.